Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Martinez

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2024
mRNA-LNP vaccine-induced CD8<sup>+</sup> T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodiesBrian Montoya, Carolina R Melo-Silva, Lingjuan Tang, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in miceDavid R Martinez, Alexandra Schafer, Tyler D Gavitt, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Broad Sarbecovirus Neutralization by an S2-Directed Plasma Antibody Defines a New Site of Vulnerability in SARS-like VirusesDouglas R Townsend, Ling Zhou, Michael L Mallory, et al.
Nature|August 28, 2020
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasuresKenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasuresKenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Cell|September 17, 2020
High Potency of a Bivalent Human V<sub>H</sub> Domain in SARS-CoV-2 Animal ModelsWei Li, Alexandra Schäfer, Swarali S Kulkarni, et al.
Science Immunology|June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patientsLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Msphere|August 25, 2021
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent IndividualsAlena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individualsAlena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus AntibodiesLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2024
mRNA-LNP vaccine-induced CD8<sup>+</sup> T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodiesBrian Montoya, Carolina R Melo-Silva, Lingjuan Tang, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in miceDavid R Martinez, Alexandra Schafer, Tyler D Gavitt, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Broad Sarbecovirus Neutralization by an S2-Directed Plasma Antibody Defines a New Site of Vulnerability in SARS-like VirusesDouglas R Townsend, Ling Zhou, Michael L Mallory, et al.
Nature|August 28, 2020
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasuresKenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasuresKenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Cell|September 17, 2020
High Potency of a Bivalent Human V<sub>H</sub> Domain in SARS-CoV-2 Animal ModelsWei Li, Alexandra Schäfer, Swarali S Kulkarni, et al.
Science Immunology|June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patientsLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Msphere|August 25, 2021
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent IndividualsAlena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individualsAlena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus AntibodiesLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Pageof 12